A Study for Expanding Application Sites for Rotigotine Transdermal Patch

The rotigotine transdermal patch (RTP) is a dopamine agonist used to treat Parkinson's disease (PD). Some PD patients cannot continue RTP treatment due to application site reactions. We explored sites for RTP where application site reactions are less severe than those in the six approved applic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kujirai, Hitoshi, Itaya, Sakiko, Ono, Yumi, Takahashi, Makoto, Inaba, Akira, Shimo, Yasushi, Hattori, Nobutaka, Orimo, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436353/
https://www.ncbi.nlm.nih.gov/pubmed/32850112
http://dx.doi.org/10.1155/2020/5892163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436353/
https://www.ncbi.nlm.nih.gov/pubmed/32850112
http://dx.doi.org/10.1155/2020/5892163

Ejemplares similares